PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Mar-2021 gaitQ Awarded Grant by the UK’s National Institute for Health Research for the continued development of its system gaitQ
29-Mar-2021 Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations Autolus Therapeutics plc
29-Mar-2021 The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government UNION therapeutics A/S
29-Mar-2021 HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies HUTCHMED
29-Mar-2021 OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer OKYO Pharma Limited
29-Mar-2021 Syncona cornerstones $148 million Series C Financing in Gyroscope Syncona Ltd
29-Mar-2021 Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation Vertex Pharmaceuticals Incorporated
29-Mar-2021 Avifavir obtains its first registration in Asia Russian Direct Investment Fund
29-Mar-2021 HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors Hutchison China MediTech Limited
29-Mar-2021 Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery University of Birmingham
29-Mar-2021 LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology Nordic Capital
29-Mar-2021 Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials Amzell BV
29-Mar-2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Augustine Therapeutics
29-Mar-2021 Sputnik V approved in Vietnam The Russian Direct Investment Fund
29-Mar-2021 DUNAD THERAPEUTICS EMERGES TO DEVELOP NEXT-GENERATION SMALL MOLECULE THERAPEUTICS BASED ON FIRST TUNEABLE TARGETED PROTEIN DEGRADATION TECHNOLOGY Dunad Therapeutics
29-Mar-2021 Pangaea Data appoints new CFO and three pharmaceutical experts as advisors Pangaea Data
29-Mar-2021 Cytel opens Solara to general release & launches new Trial Optimization Solution for Biotechs Cytel
26-Mar-2021 Bristol Myers Squibb Announces RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in Patients with Previously Untreated Metastatic or Unresectable Melanoma, Meets Primary Endpoint of Progression-Free Survival Bristol Myers Squibb
26-Mar-2021 Optometry Medical Billing Services-Why Outsourcing Can Be Good? 24/7 Medical Billing Services
26-Mar-2021 3 Important ICD 10 Codes for OB GYN Medical Billing 24/7 Medical Billing Services